Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma × atezolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 36 Triple Negative Breast Neoplasms 16 Carcinoma, Transitional Cell 14 Breast Neoplasms 14 Small Cell Lung Carcinoma 12 Urinary Bladder Neoplasms 11 Melanoma 10 Carcinoma, Hepatocellular 9 Neoplasms 8 Carcinoma, Renal Cell 8 Uterine Cervical Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Colorectal Neoplasms 5 Ovarian Neoplasms 4 Lymphoma, Follicular 4 Lymphoma 4 Recurrence 3 Leukemia, Myeloid, Acute 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Kidney Neoplasms 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2

Interventions

Irinotecan 7 Cyclophosphamide 7 Vincristine 6 Magnetic Resonance Spectroscopy 5 Dactinomycin 5 temsirolimus 4 cixutumumab 4 X-Rays 4 Sirolimus 4 Radiotherapy 4 Phantoms, Imaging 4 Etoposide 4 Doxorubicin 4 Specimen Handling 3 Radiation 3 Peripheral Blood Stem Cell Transplantation 3 Nuclear Medicine Department, Hospital 3 Melphalan 3 Ifosfamide 3 Gemcitabine 3 Filgrastim 3 ulixertinib 2 tipifarnib 2 thymoglobulin 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 larotrectinib 2 ivosidenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡